Pharmacology and pathophysiology of dopaminergic neurons.
D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D001480:Basal Ganglia Diseases / Q000139:chemically induced; D001921:Brain / Q000502:physiology; D002090:Butyrophenones / Q000009:adverse effects; D002415:Cats; D002417:Cattle; D004298:Dopamine / Q000502:physiology*; D005724:Ganglia / Q000187:drug effects; D006041:Goats; D006801:Humans; D007668:Kidney / Q000187:drug effects; D007700:Kinetics; D009474:Neurons / Q000187:drug effects / Q000502:physiology*; D009638:Norepinephrine / Q000502:physiology; D010300:Parkinson Disease / Q000503:physiopathology; D010640:Phenothiazines / Q000009:adverse effects; D011817:Rabbits; D011941:Receptors, Adrenergic; D012756:Sheep; D012908:Snails; D013239:Stereotyped Behavior / Q000187:drug effects; D013329:Structure-Activity Relationship; D014149:Tranquilizing Agents / Q000009:adverse effects / Q000494:pharmacology
D002090:Butyrophenones; D010640:Phenothiazines; D011941:Receptors, Adrenergic; D014149:Tranquilizing Agents; D000661:Amphetamine; D004298:Dopamine; D009638:Norepinephrine